Position in URGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$665,260
-$201,280 QoQ
Shares Held
37,000
0.0% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Coastal Bridge Advisors, LLC holds $9,671,803 across 13 Biotechnology names. URGN ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
22,175 | $2,087,111 | |
| 2 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
276,817 | $1,696,888 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
3,906 | $1,258,474 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,521 | $1,175,185 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
14,500 | $937,135 | |
| 6 | URGN |
UroGen Pharma Ltd.
This page
|
37,000 | $665,260 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
13,102 | $520,411 | |
| 8 | SPRY |
ARS Pharmaceuticals, Inc.
|
55,730 | $447,511 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $665,260 | 37,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $866,540 | 37,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $738,150 | 37,000 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $506,900 | 37,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $409,220 | 37,000 | Shares | Sole | 2025-08-25 | |
| 2024-12-31 | $415,350 | 39,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $514,350 | 40,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $646,030 | 38,500 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $555,000 | 37,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $566,250 | 37,750 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $539,385 | 38,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $390,526 | 37,732 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $341,880 | 37,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $328,190 | 37,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $307,840 | 37,000 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $303,030 | 37,000 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $330,980 | 38,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $703,740 | 74,000 | Shares | Sole | 2022-05-20 | |
| 2021-09-30 | $622,340 | 37,000 | Shares | Sole | 2022-05-20 | |
| 2021-06-30 | $564,990 | 37,000 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $720,760 | 37,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $666,740 | 37,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $713,730 | 37,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $966,440 | 37,000 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $660,080 | 37,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||